Clinical Trial Update: The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism [Phase 4]

View source ↗

Summary

This Phase 4 trial examines the effects of testosterone replacement therapy on FGF-23, asymmetric dimethylarginine, and vitamin D levels in men with congenital …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypogonadotropic Hypogonadism
• Hypogonadism

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Hypogonadism | Phase 4 | Status: COMPLETED